Article
Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
Cancer biomarkers : section A of Disease markers - 1 Jan 2017
Hashemi Mohammad, Danesh Hiva, Bizhani Fatemeh, Narouie Behzad, Sotoudeh Mehdi, Nouralizadeh Akbar, Sharifiaghdas Farzaneh, Bahari Gholamreza, Taheri Mohsen
Abstract excerpt
The association studies between miR-34b/c rs4938723 polymorphism and cancer risk showed conflicting results. This study aimed to assess the impact of rs4938723 polymorphism on prostate cancer risk. This case-control study was done on 151 prostate cancer (PCa) patients and 152 benign prostate hyperplasia to examine whether rs4938723 polymorphism in the promoter of pri-miR-34b/c was linked to the carcinogenesis of...
Read the complete abstract on PubMed